Advances in Heart Failure - Is it Time to Redefine Patient Selection for Sodium-glucose co-transporter 2 Inhibitors? - Organised by Radcliffe Medical Education, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an education